Two Sigma Investments’s Praxis Precision Medicines PRAX Stock Holding History
Bought
Maintained
Sold
Other funds holding PRAX
JT
PA
BBA
OAG
Two Sigma Investments's PRAX Position: Q2 2026 in Review
Two Sigma Investments increased its Praxis Precision Medicines (PRAX) stake by 6.6% in Q2 2026, buying an estimated $367K and bringing the position to 18,758 shares worth $6.28M. The position accounts for ﹤0.01% of the portfolio, ranked #1926.
Two Sigma Investments first reported a position in PRAX in Q2 2021 and has held it in 21 quarters since. The position peaked at $6.81M in Q4 2025. 310 funds tracked by Wall St. Rank hold PRAX as of Q2 2026.
- Two Sigma Investments held 18,758 shares of Praxis Precision Medicines worth $6.28M as of Q2 2026.
- Two Sigma Investments bought 1,160 Praxis Precision Medicines shares in Q2 2026, an estimated $367K.
- Praxis Precision Medicines made up ﹤0.01% of Two Sigma Investments's portfolio in Q2 2026, its #1926 holding.
- Two Sigma Investments first reported a position in Praxis Precision Medicines in Q2 2021 and has held it in 21 quarters since.
- Two Sigma Investments's Praxis Precision Medicines position peaked at $6.81M in Q4 2025.
- 310 funds tracked by Wall St. Rank held Praxis Precision Medicines as of Q2 2026.
Based on Two Sigma Investments's 13F filing for Q2 2026, filed 14 Aug 2026.